An mRNA vaccine produced by Moderna and Merck reduced the risk of skin cancer metastasis or death by 65%, according to clinical trial results shared at the 2023 session of the American Society of...
On June 1, 2023, the National Cancer Institute (NCI), a subset of the NIH, launched ComboMATCH, a precision medicine initiative for cancer patients. ComboMATCH — short for Combination Therapy...
Nearly every medical device or pharmaceutical company has a medical affairs team responsible for gathering scientific data and communicating it with leaders in the pharmaceutical industry. However, a...
An open-label, randomized, noninferiority trial published in the New England Journal of Medicine revealed that ketamine and electroconvulsive therapy (ECT) were equally effective at managing...
The drug development process is a notably tricky component of the pharmaceutical industry, accounting for the most time and money required to get a drug to market. Across the United States, the average spending on drug development is...
On May 18, 2023, the United States Food and Drug Administration (FDA) approved RINVOQ, manufactured by Abbvie, as a once-daily treatment for adults with moderate or severely active Crohn’s...
On May 16, 2023, the Foundation for the National Institutes of Health (FNIH) announced eight rare diseases to be explored by the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC). As one of the newest additions...
Adding to the significant progression of mRNA vaccines in cancer care, Memorial Sloan Kettering Cancer Center (MSKCC) researchers have announced promising results from a phase 1 clinical trial using...
On May 11, 2023, the United States FDA Pulmonary–Allergy Drug Advisory Committee (PADAC) favored the approval of Neffy, the first intranasal epinephrine spray for allergic reactions. The panel...
According to 2017 CDC data, over 31,000 people are living with amyotrophic lateral sclerosis (ALS) in the United States. In America, approximately 5,000 individuals are diagnosed with ALS annually. ALS is associated with high costs, as the...
Yesterday, the United States Department of Agriculture (USDA) conditionally licensed an oral vaccine for Borrelia burgdorferi, the bacteria that causes Lyme disease. LymeShield, the product...
In an announcement issued earlier this year, Eli Lilly is celebrating the success of Mounjaro in achieving 15.7% weight loss across 72 weeks for obese or overweight adults with type 2 diabetes (T2D)....
A recent study published in the Annals of Neurology identified a link between sleeping pill use and lowered levels of Alzheimer's disease protein. Protein buildups and plaques identified in...
Data from the WHO estimates that 230 million people globally have depression. Although many traditional treatments exist for depression, roughly 33% of people do not respond to medications. As a result, researchers have searched for...
Despite valiant efforts by other pharmaceutical companies — namely, Pfizer — GSK has secured its spot in the respiratory syncytial virus (RSV) vaccine market, becoming the first-ever...
Yesterday, the FDA published a copy of its draft guidance for decentralized clinical trials, adding to previously issued guidelines. Clinical trial participants may be able to bring trials to their...
Clinical trials are currently the gold standard for proving the efficacy and safety of new treatments for regulatory approval. Globally, clinical trial data supports medical decisions and drug development. Each year, hundreds of thousands...
An analysis of the impact of the National Institutes of Health (NIH) funding requirements determined that they improve diversity in medical scientist training programs (MSTPs). The data revealed more...
While the pharmaceutical industry and its stakeholders constantly develop and advance new drugs, products, and treatments, the drug development life cycle always needs new discoveries and additions in...
In a news release published Tuesday, the FDA announced that most individuals who already received a bivalent booster vaccine would not be eligible for another dose. FDA officials said they intend to...
